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Introduction 
Diabetes mellitus is a very common metabolic disorder 
characterized  by  hyperglycemia  and  insufficiency  of 
secretion  or  action  of  endogenous  insulin.
1  Diabetes 
causes  complications  affecting  the  retina,  kidney, 
muscle and blood vessels, and the nervous system.
2  
Many studies show that changes in cerebral structure 
and function in diabetes are related to hyperglycemia-
induced  end  organ  damage,  macrovascular  disease, 
hypoglycemia, insulin resistance, and amyloid lesions.
3 
On the one hand, diabetes induces cytochrome c release 
from mitochondria into cytoplasm that may play a role 
in  apoptosis  of  the  CA1  pyramidal  neurons.
4  On  the 
other  hand,  diabetes  causes  a  reduction  in 
neurogenesis.
5  
There  are  also  electrophysiological  and  structural 
abnormalities of the brain in diabetic patients providing 
good reasons to believe that cognitive functions may be 
impaired  in  diabetes  mellitus.
6  Moreover,  oxidative 
stress could contribute to learning and memory deficits 
in diabetes.
7 
Loganin as an iridoid glycoside first was found in Flos 
lonicerae, Fruit cornus, and Strychonos nux vomica.
8 It 
has been used as a traditional medicine in Japan and 
China.
9 According to one study, loganin has a plasma 
glucose  lowering  action  in  normal  rats  and  regulates 
immune  function  and  has  anti-inflammatory, 
neuroprotective and anti-shock effects.
8,9 
In  an  Alzheimer's  model  of  study,  Kwon  and 
colleagues proved that loganin could have anti-amnesic 
and  anti  acetylcholinesterase  activity  in  the 
hippocampus  and  frontal  cortex.
10  Furthermore,  our 
recent  studies  showed  that  acute  administration  of 
loganin  improves  memory  in  passive  avoidance  tests 
and chronic application of it exhibits protective effect 
on spatial learning and memory in diabetic rats.
11,12 
In  this  study,  we  evaluated  the  effect  of  acute  oral 
administration  of  loganin  on  learning  and  memory 
deficits in one and 12 weeks diabetic rats in the Morris 
water maze tasks.  
 
Materials and Methods 
Streptozotocin  (STZ)  was  purchased  from  Tocris 
Bioscience (Bristol, UK) and dissolved in normal saline 
immediately before use. Loganin was purchased from 
Extrasynthese (France) and dissolved in normal saline. 
 
Animals 
Male Wistar rats, weighing (250–300) g, were used in 
the present experiment. All animals were maintained at 
a constant temperature (20±1) and on a 12 h light: 12 h 
dark cycle. They had free access to water and food ad 
libitum.  The  Regional  Ethics  Committee  of  Tabriz 
University  of  Medical  Sciences  approved  all 
experimental procedures. 
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Purpose: Diabetes is associated with memory and learning disorder. The purpose of this 
study is to determine the effect of acute oral administration of loganin on memory in 
diabetic male rats. Methods: 42 male Wistar rats (250-300 g) were divided into six 
groups: Control, Diabetic (1 week), Diabetic (12 weeks), Loganin, Diabetic (1 week) + 
Loganin,  Diabetic  (12  weeks)  +  Loganin.  Diabetes  was  induced  by  IP  injection  of 
Streptozotocin (60 mg/kg). Loganin (40 mg/kg, po) was administrated 1 hour before 
test. Then,  spatial  memory  was compared between  groups  with Morris Water Maze 
tests.  Results:  Administration  of  loganin  during  acquisition,  significantly  (p<0.05) 
decreased both escape latency and traveled distance to find hidden platform in 1 and 12 
weeks  diabetic  rats.  In  evaluation  of  recall  phase  of  memory,  loganin  significantly 
(p<0.05) increased time and distance spent in the target quadrant in 1 and 12 weeks 
diabetic  rats.  Conclusion:  Acute  administration  of  loganin  could  improve  spatial 
memory in diabetic rats. 
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Experimental Design 
Male Wistar rats (n = 42) were divided into six groups 
(n = 7 each): control, diabetic (1 week), diabetic (12 
week), loganin, diabetic (1 week) + loganin, diabetics 
(12  week)  +  loganin.  Experimental  diabetes  was 
induced  by  a  single  dose  of  STZ  (60  mg/kg, 
intraperitoneal  (ip)).  Three  days  after  STZ  injection, 
fasting blood glucose levels were determined. Animals 
were  considered  diabetic  if  plasma  glucose  levels 
exceeded  300  mg/dl.
13  Loganin  (40  mg/kg,  po)  was 
administrated once after confirming diabetes. Animals 
were  tested  for  spatial  memory  1  h  after  loganin 
treatment.
10 
 
Morris Water Maze Test 
The Morris water maze was black circular pool (136 
cm in diameter and 100 cm in height). The pool was 
filled to a depth of 60 cm with water (20±1 °C) and 
divided into four quadrants of equal area (NE, SE, SW 
and NW). A platform (10 cm in diameter) was centered 
in one of the four quadrants of the pool and submerged 
1 cm below the water surface so that it was invisible at 
water level. The swimming was monitored by a video 
camera, which was positioned directly above the center 
of the pool. The pool was located in a test room, which 
contained various prominent visual cues.
14  
One  week  after  surgery,  the  rats  were  trained  in  the 
water  maze.  The  single  training  session  consisted  of 
eight trials (in two blocks) with four different starting 
positions  that  were  equally  distributed  around  the 
perimeter of the maze. The task requires rats to swim to 
the hidden platform guided by distal spatial cues. After 
mounting the platform, the rats were allowed to remain 
there for 20 s, and then were placed in a holding cage 
for 30 s until the start of the next trial. Rats were given 
a maximum of 60 s to find the platform and if it failed 
to  find  the  platform  in  60  s,  it  was  placed  on  the 
platform  and  allowed  to  rest  for  20  s.  Latency  to 
platform  and  distance  traveled  were  collected  and 
analyzed  later.  After  completion  of  the  training,  the 
animals  were  returned  to  their  home  cages  until 
retention testing 24 h later. The probe trial consisted of 
60 s free swim period without a platform and the time 
swum in the target quadrant was recorded. 
In order to assess the possibility of drug interference 
with  animal  sensory  and  motor  coordination  or  the 
animal motivation, the capability of rats to escape to a 
visible platform was tested in this study. The trained 
rats were given four trials for visuo-motor coordination 
on the visible platform.
15  
 
Statistics  
SPSS  13.0  software  was  used  for  statistical 
comparisons of data, and data expressed as the means ± 
SEM. For comparisons between Block 1 and Block 2 in 
each  group,  a  paired-sample  T  test  was  used.  The 
statistical  analysis  of  the  data  between  groups  was 
carried  out  by  one-way  ANOVA  followed  by  Tukey 
test. In all comparisons, P<0.05 was the criterion for 
statistical significance. 
 
Results 
In  comparison  of  block  1  and  block  2,  diabetes 
increased escape latency and traveled distance (Figures 
1, 2) in 1 and 12 weeks diabetic rats during acquisition 
phase.  Loganin  (40  mg/kg)  significantly  decreased 
latency time (P<0.05) and traveled distance (P<0.05) in 
1 and 12 weeks diabetic rats. 
 
 
Figure  1.  Effect  of  loganin  on  the  traveled  distance  to  find 
hidden platform in two consecutive blocks (b1 and b2). In the 
diabetic rats, loganin (40 mg/kg, po) were administered 60 min 
before  the  tests.  Data  represent  means  ±  S.E.M.  (n=7). 
*P<0.05,  significantly  different  when  compared  with  the  b1 
same group. 
 
 
Figure 2. Effect of loganin on the escape latency to find hidden 
platform in two consecutive blocks (b1 and b2). In the diabetic 
rats, loganin (40 mg/kg, po) were administered 60 min before 
the  tests.  Data  represent  means  ±  S.E.M.  (n=7).  *P<0.05, 
significantly different when compared with the b1 same group. 
 
Probe test data were compared between groups. One-
way  ANOVA  of  the  distance  traveled  in  the  target 
quadrant  revealed  significant  differences  (P<0.05) 
between groups. Loganin (40 mg/kg) increased the time 
and distance in the target quadrant after the platform 
was removed (Figures 3, 4). No treatments significantly 
changed swimming speed in the target quadrant (Figure 5). 
Loganin  gavage  60  min  before  visual  trial  (visible 
platform) also showed no difference in escape latency 
and  traveled  distance  to  find  the  visible  platform, 
compared to the control group (data are not shown).  
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Figure  3.  Effect  of  loganin  on  the  traveled  distance  in  trial 
sessions  of  the  Morris  water  maze  test.    Data  represent 
means± S.E.M. (n=7). 
*P<0.05 significantly different when compared with the control 
group. 
#P<0.05 significantly different when compared with the 1 week 
diabetic group. 
ФP<0.05 significantly  different  when  compared  with  the  12 
weeks diabetic group. 
 
 
Figure  4.  Effect  of  loganin  on  the  escape  latency  in  trial 
sessions  of  the  Morris  water  maze  test.    Data  represent 
means± S.E.M. (n=7). 
*P<0.05 significantly different when compared with the control 
group. 
#P<0.05 significantly different when compared with the 1 week 
diabetic group. 
ФP<0.05 significantly  different  when  compared  with  the  12 
weeks diabetic group. 
  
 
Figure  5.  Effect  of  loganin  on  the  swimming  speed  in  trial 
sessions  of  the  Morris  water  maze  test.    Data  represent 
means± S.E.M. (n=7). Loganin did not change the swimming 
speed. 
 
 
Discussion 
In the present study, loganin was used for the first time 
in  evaluating  memory  impairment  of  Streptozotocin-
induced diabetes. Our results showed that diabetic (1, 
12  weeks)  rats  had  an  increased  escape  latency  time 
and traveled distance to find the hidden platform in a 
MWM task. Loganin administration with a dose of 40 
mg/kg/po  improved  the  acquisition  and  retrieval  in 
diabetic  rats.  In  addition,  the  results  of  the  visible 
platform  test  suggest  that  loganin  does  not  have  an 
effect on mood or sensorimotor activity in rats; rather, 
it  appears  to  shorten  escape  latency  by  enhancing 
memory due  to  the effect  on  brain areas  involved  in 
memory consolidation, such as the hippocampus. 
Diabetes mellitus is a chronic disease characterized by 
widespread complications in CNS and PNS.
16 Learning 
and  memory  in  animal  model  of  diabetes  are 
impaired.
17  Chronic  hyperglycemia  is  associated  with 
oxidative  stress-induced  neuronal  and  Schwann  cell 
death  and  the  reduction  of  neural  size  in  the  rat 
brain.
18,19 Also, learning deficits in diabetic rats have 
been associated with changes in hippocampal synaptic 
plasticity.
20  
As  previously  mentioned,  loganin  is  an  iridoid 
glycoside  that  is  found  in  many  traditional  Chinese, 
Japan,  and  Korea  herbs.
10  Loganin,  is  an  active 
compound and was found to exhibit immune-regulating 
and  anti-inflammatory  activity.
21,22  It  has  hepato-
protective,  renal  protective  and  neuroprotective 
effects.
8,23,24  
In addition Kwon and colleagues showed that loganin 
may  have  anti-amnesic  activity  in  alleviating  certain 
memory  impairments  observed  in  Alzheimer's 
disease.
10  Our  recent  study  also  showed  that  loganin 
improves passive avoidance learning in diabetic male 
rats.
11  
Although the exact mechanism of action of loganin on 
diabetic deficit of learning and memory is not clear, it 
may  act  by  preventing  oxidative  stress,  inhibiting  
acetyl cholinesterase activity  in the hippocampus  and 
inhibiting  advanced  glycation  end  product  formation 
and  NF-κB  induced  inflammation  in  the  hepatic 
tissue.
10,25,26  Some  other  possible  mechanisms  of 
loganin  action  include  inhibition  of  release  of  Cyt-c 
from  mitochondria  into  cytoplasm  of  hippocampal 
pyramidal  neurons  and  reduction  of  apoptosis  levels 
and induction of neurogenesis and angiogenesis in the 
brain.
4,8,27  
Nevertheless, further studies are needed to increase the 
understanding of the physiological mechanisms leading 
to this memory enhancing effect of loganin. 
 
Conclusion 
In  summary,  our  results  suggested  that  loganin 
alleviates  diabetes-induced  memory  impairments. 
Therefore,  loganin  could  be  used  as  an  agent  of 
treatment for the learning and memory-deficit cause by 
diabetes. 
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